Publications - 'G'
Publications 651 - 675 de 686
| Titre | DOI |
|---|---|
|
Guide to good practices to ensure privacy protection in secondary use of medical records C. Riou; J. Fresson; J.L. Serre; P. Avillach; L. Leneveut; C. Quantin; G.Travail CIMES; CUESP; CNIM; CCTIRS; CNIL 2014 |
10.1016/j.respe.2014.03.005 |
|
Guided Lamb waves in reconfigurable phononic crystal waveguides Y.F. Wang; L. Yang; T.T. Wang; A.L. Chen; V. Laude; Y.S. Wang 2021 |
10.1063/5.0056202 |
|
Guided resonances on lithium niobate for extremely small electric field detection investigated by accurate sensitivity analysis W. Qiu; A. Ndao; H. Lu; M.P. Bernal; F.Issam Baida 2016 |
10.1364/OE.24.020196 |
|
Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update M. Moorhouse; L.G. Bekker; V. Black; F. Conradie; B. Harley; P. Howell; G. Maartens; T. Papavarnavas; K. Rebe; G. Sorour; F. Venter; C.L. Wallis 2015 |
10.4102/sajhivmed.v16i1.399 |
|
Guidelines for methacholine provocation testing L. Plantier; N. Beydon; A. Chambellan; B. Degano; C. Delclaux; J.D. Dewitte; A.T. Dinh-Xuan; G. Garcia; C. Kauffnnan; C. Paris; T. Perez; M. Poussel; B. Wuyam; F. Zerah-Lancner; B. Chenuel; G.Fonction SPLF 2018 |
10.1016/j.rmr.2018.02.010 |
|
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations P. Pujol; P.Vande Perre; L. Faivre; D. Sanlaville; C. Corsini; B. Baertschi; M. Anahory; D. Vaur; S. Olschwang; N. Soufir; N. Bastide; S. Amar; M. Vintraud; O. Ingster; S. Richard; P. Le Coz; J.P. Spano; O. Caron; P. Hammel; E. Luporsi; A. Toledano; X. Rebillard; A. Cambon-Thomsen; O. Putois; J.M. Rey; C. Herve; C. Zorn; K. Baudry; V. Galibert; J. Gligorov; D. Azria; B.Bressac de Paillerets; N. Burnichon; M. Spielmann; D. Zarca; I. Coupier; O. Cussenot; A.P. Gimenez-Roqueplo; S. Giraud; A.S. Lapointe; P. Niccoli; I. Raingeard; M. Le Bidan; T. Frebourg; A. Rafii; D. Genevieve 2018 |
10.1038/s41431-018-0224-1 |
|
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations P. Pujol; P. Van de Perre; L. Faivre; D. Sanlaville; C. Corsini; B. Baertschi; M. Anahory; D. Vaur; S. Olschwang; N. Soufir; N. Bastide; S. Amar; M. Vintraud; O. Ingster; S. Richard; P. Le Coz; J. Spano; O. Caron; P. Hammel; E. Luporsi; A. Toledano; X. Rebillard; A. Cambon-Thomsen; O. Putois; J. Rey; C. Herve; C. Zorn; K. Baudry; V. Galibert; J. Gligorov; D. Azria; B. De Paillerets; N. Burnichon; M. Spielmann; D. Zarca; I. Coupier; O. Cussenot; A. Gimenez-Roqueplo; S. Giraud; A. Lapointe; P. Niccoli; I. Raingeard; M. Le Bidan; T. Frebourg; A. Rafii; D. Genevieve 2019 |
|
|
Guidelines for stage I to Ill melanoma B. Guillot; S. Dalac; M. Denis; A. Dupuy; J.Francois Emile; A. De La Fouchardiere; E. Hindie; T. Jouary; N. Lassau; X. Mirabel; S.Piperno Neumann; S. De Raucourt; R. Vanwijck 2016 |
10.1016/j.bulcan.2016.06.002 |
|
Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period - FRANCOGYN group for the CNGOF C. Akladios; H. Azais; M. Ballester; S. Bendifallah; P.A. Bolze; N. Bourdel; A. Bricou; G. Canlorbe; X. Carcopino; P. Chauvet; P. Collinet; C. Coutant; Y. Dabi; L. Dion; T. Gauthier; O. Graesslin; C. Huchon; M. Koskas; F. Kridelka; V. Lavoue; L. Lecointre; M. Mezzadri; C. Mimoun; L. Ouldamer; E. Raimond; C. Touboul 2020 |
10.1016/j.gofs.2020.03.017 |
|
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro) A. Kramar; S. Negrier; R. Sylvester; S. Joniau; P. Mulders; T. Powles; A. Bex; F. Bonnetain; A. Bossi; S. Bracarda; R. Bukowski; J. Catto; T.K. Choueiri; S. Crabb; T. Eisen; E. Demery; J. Fitzpatrick; V. Flamand; P.J. Goebell; G. Gravis; N. Houede; D. Jacqmin; R. Kaplan; B. Malavaud; C. Massard; B. Melichar; L. Mourey; P. Nathan; D. Pasquier; C. Porta; D. Pouessel; D. Quinn; A. Ravaud; F. Rolland; M. Schmidinger; B. Tombal; D. Tosi; E. Vauleon; A. Volpe; P. Wolter; B. Escudier; T. Filleron; D.A.T.E.C.A.N.Renal Can Grp 2015 |
10.1093/annonc/mdv380 |
|
Guidelines for the probabilistic treatment of community-acquired pneumonia: Compared experience between internal medicine and emergency departments in the University Hospital of Besancon, France H. Gil; F. Grenier; J. Leroy; G. Tisserand; N. Meaux-Ruault; N. Magy-Bertrand 2014 |
10.1016/j.revmed.2013.03.001 |
|
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) S. Gourgou-Bourgade; D. Cameron; P. Poortmans; B. Asselain; D. Azria; F. Cardoso; R. A'Hern; J. Bliss; J. Bogaerts; H. Bonnefoi; E. Brain; M.J. Cardoso; B. Chibaudel; R. Coleman; T. Cufer; L. Dal Lago; F. Dalenc; E. De Azambuja; M. Debled; S. Delaloge; T. Filleron; J. Gligorov; M. Gutowski; W. Jacot; C. Kirkove; G. MacGrogan; S. Michiels; I. Negreiros; B.V. Offersen; P. Llorca; G. Pruneri; H. Roche; N.S. Russell; F. Schmitt; V. Servent; B. Thuerlimann; M. Untch; J.A. van der Hage; G. van Tienhoven; H. Wildiers; J. Yarnold; F. Bonnetain; S. Mathoulin-Pelissier; C. Bellera; T.S. Dabakuyo-Yonli 2015 |
10.1093/annonc/mdv106 |
|
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) C.A. Bellera; N. Penel; M. Ouali; S. Bonvalot; P.G. Casali; O.S. Nielsen; M. Delannes; S. Litiere; F. Bonnetain; T.S. Dabakuyo; R.S. Benjamin; J.Y. Blay; B.N. Bui; F. Collin; T.F. Delaney; F. Duffaud; T. Filleron; M. Fiore; H. Gelderblom; S. George; R. Grimer; P. Grosclaude; A. Gronchi; R. Haas; P. Hohenberger; R. Issels; A. Italiano; V. Jooste; A. Krarup-Hansen; C. Le Pechoux; C. Mussi; O. Oberlin; S. Patel; S. Piperno-Neumann; C. Raut; I. Ray-Coquard; P. Rutkowski; S. Schuetze; S. Sleijfer; E. Stoeckle; M. Van Glabbeke; P. Woll; S. Gourgou-Bourgade; S. Mathoulin-Pelissier 2015 |
10.1093/annonc/mdu360 |
|
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative R. Cohen; D. Vernerey; C. Bellera; A. Meurisse; J. Henriques; X. Paoletti; B. Rousseau; S. Alberts; T. Aparicio; I. Boukovinas; S. Gill; R.M. Goldberg; A. Grothey; T. Hamaguchi; T. Iveson; R. Kerr; R. Labianca; S. Lonardi; J. Meyerhardt; J. Paul; C.J.A. Punt; L. Saltz; M.P. Saunders; H.J. Schmoll; M. Shah; A. Sobrero; I. Souglakos; J. Taieb; A. Takashima; A.Dorothea Wagner; M. Ychou; F. Bonnetain; S. Gourgou; T. Yoshino; G. Yothers; A. de Gramont; Q. Shi; T. Andre; A.C.C.E.N.T. Grp 2020 |
10.1016/j.ejca.2020.02.009 |
|
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials) F. Bonnetain; B. Bonsing; T. Conroy; A. Dousseau; B. Glimelius; K. Haustermans; F. Lacaine; J.Luc Van Laethem; T. Aparicio; D. Aust; C. Bassi; V. Berger; E. Chamorey; B. Chibaudel; L. Dahan; A. de Gramont; J.Robert Delpero; C. Dervenis; M. Ducreux; J. Gal; E. Gerber; P. Ghaneh; P. Hammel; A. Hendlisz; V. Jooste; R. Labianca; A. Latouche; M. Lutz; T. Macarulla; D. Malka; M. Mauer; E. Mitry; J. Neoptolemos; P. Pessaux; A. Sauvanet; J. Tabernero; J. Taieb; G. van Tienhoven; S. Gourgou-Bourgade; C. Bellera; S. Mathoulin-Pelissier; L. Collette 2014 |
10.1016/j.ejca.2014.07.011 |
|
Guidelines on enhanced recovery after pulmonary lobectomy P. Berna; C. Quesnel; J. Assouad; P. Bagan; H. Etienne; A. Fourdrain; M. Le Guen; M. Leone; E. Lorne; Y.L. Nguyen; P.B. Pages; H. Roze; M. Garnier 2021 |
10.1016/j.accpm.2020.100791 |
|
Guidelines on the management of infectious encephalitis in adults J.P. Stahl; P. Azouvi; F. Bruneel; T. de Broucker; X. Duval; B. Fantin; N. Girard; J.L. Herrmann; J. Honnorat; M. Lecuit; A. Mailles; L. Martinez-Almoyna; P. Morand; L. Piroth; P. Tattevin; R. Grp 2017 |
10.1016/j.medmal.2017.01.005 |
|
Guidelines: Anaesthesia in the context of COVID-19 pandemic L. Velly; E. Gayat; H. Quintard; E. Weiss; A. De Jong; P. Cuvillon; G. Audibert; J. Amour; M. Beaussier; M. Biais; S. Bloc; M.Pierre Bonnet; P. Bouzat; G. Brezac; C. Dahyot-Fizelier; S. Dahmani; M. de Queiroz; S. Di Maria; C. Ecoffey; E. Futier; T. Geeraerts; H. Jaber; L. Heyer; R. Hoteit; O. Joannes-Boyau; D. Kern; O. Langeron; S. Lasocki; Y. Launey; F. le Sache; A.Claire Lukaszewicz; A. Maurice-Szamburski; N. Mayeur; F. Michel; V. Minville; S. Mirek; P. Montravers; E. Morau; L. Muller; J. Muret; K. Nouette-Gaulain; J.Christophe Orban; G. Orliaguet; P.Francois Perrigault; F. Plantet; J. Pottecher; C. Quesnel; V. Reubrecht; B. Rozec; B. Tavernier; B. Veber; F. Veyckmans; H. Charbonneau; I. Constant; D. Frasca; M.O. Fischer; C. Huraux; A. Blet; M. Garnier 2020 |
10.1016/j.accpm.2020.05.012 |
|
Guiding and confinement of interface acoustic waves in solid-fluid pillar-based phononic crystals M.F.Mohd Ra Wee; M. Addouche; K.S. Siow; A.R.Md Zain; A. Elayouch; F. Chollet; A. Khelif 2016 |
10.1063/1.4968609 |
|
Guiding and splitting Lamb waves in coupled-resonator elastic waveguides Y.F. Wang; T.T. Wang; J.P. Liu; Y.S. Wang; V. Laude 2018 |
10.1016/j.compstruct.2018.08.088 |
|
Guillain-Barre syndrome in the COVID-19 era: another occasional cluster? L. Tatu; S. Nono; S. Gracio; S. Kocer 2021 |
10.1007/s00415-020-10005-3 |
|
Guillain-Barre syndrome in the COVID-19 era: another occasional cluster? L. Tatu; S. Nono; S. Gracio; S. Kocer Submitted |
10.1007/s00415-020-10005-3, Early Access Date = {JUN 2020 |
|
Guillaume du Bellay, the guardian angel of Francois I M. Barral-Baron 2017 |
|
|
Gum Metal thin films obtained by magnetron sputtering of a Ti-Nb-Zr-Ta target S. Achache; S. Lamri; A. Alhussein; A. Billard; M. Francois; F. Sanchette 2016 |
10.1016/j.msea.2016.07.096 |
|
Gustatory evoked cortical activity in humans in response to saccharin stimuli A. Jacquin; S. Meillon; V. Gigot; L. Penicaud; L. Brondel 2014 |